Last reviewed · How we verify

NCT05943912

Myopia Control Effect of DIMS Spectacle Lenses in Czech Children and Young Adults

Active, enrolled Last updated 2 April 2024
What this trial tests

trial testing Single Vision Spectacle Lens in Myopia in 80 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
17 April 2023
Primary endpoint
10 October 2026
12 December 2026

Quick facts

Lead sponsorCzech Technical University in Prague
StatusActive, enrolled
Study typeOBSERVATIONAL
Enrollment80
Start date17 April 2023
Primary completion10 October 2026
Estimated completion12 December 2026
Sites1 location across Czechia

Drugs / interventions tested

Conditions studied

Sponsor

Czech Technical University in Prague

Who can join

Adults 6 to 26, any sex, with Myopia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this clinical study is to compare the efficacy of DIMS technology spectacle lenses with conventional single vision spectacle lenses at slowing the progression of myopia in the category of children and young adults during three years.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Efficacy of Spectacle Correction Using Defocus Incorporated Multiple Segments in the Myopic Population.
    Zakova M, Fus M, Tejkl L. · · 2025 · PMID 40927114 · DOI 10.2147/opth.s541232

Verify or expand the search:

Other recruiting trials for Myopia

Currently open trials in the same condition.

Other Czech Technical University in Prague trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05943912.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing